Abbott's White saw compensation drop in 2011

Abbott Laboratories ($ABT) had a memorable 2011 capped off by announcing that it would split into two companies: a pharma business and a medical products company. CEO Miles White (pictured), who will continue to lead the diversified medical products company, saw his total compensation fall slightly in 2011, coming in at just above $24 million. That's down about 6% from $25.6 million a year earlier.  

White's base salary increased slightly to $1.9 million--up from just over $1.89 million in 2010. However, he took a hit in stock and option awards; they were $9.76 million and $1.84 million, respectively, last year and $10.9 million and $2.73 million the year prior.

Still, he fared better than Richard Gonzalez, who will head up the soon-to-be separate research-based pharmaceuticals unit; Gonzalez saw his total compensation package fall from $7.6 million to $5.56 million.

White's compensation ranks highly in the biopharma world. But how does it compare with others in the device space? Well, former Medtronic CEO Bill Hawkins raked in $9.6 million in that company's fiscal year 2011. Siemens head Peter Löscher took in roughly €8.56 million (about $11.4 million), while Siemens Healthcare chief Hermann Requardt got €3.81 million (around $5 million).

But topping them all is Johnson & Johnson CEO Bill Weldon. His 2010 compensation was more than $28 million, and he's due a $3.1 million bonus this year.

- see Abbott's SEC filing

Special Report: Miles White - 2010 CEO Pay

Suggested Articles

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.